Ocular Therapeutix Aktie
9,41
EUR
+0,21
EUR
+2,28
%
10,85
USD
+0,23
USD
+2,17
%
Werbung
Ocular Therapeutix Aktie Analyse
| 21.05.19 | Ocular Therapeutix Buy | H.C. Wainwright & Co. | |
| 03.12.18 | Ocular Therapeutix Overweight | Cantor Fitzgerald | |
| 26.07.17 | Ocular Therapeutix Buy | H.C. Wainwright & Co. | |
| 12.07.17 | Ocular Therapeutix Overweight | Cantor Fitzgerald | |
| 10.02.17 | Ocular Therapeutix Overweight | Cantor Fitzgerald | |
| 15.11.16 | Ocular Therapeutix Outperform | RBC Capital Markets | |
| 08.04.15 | Ocular Therapeutix Outperform | RBC Capital Markets | |
| 11.03.15 | Ocular Therapeutix Outperform | Oppenheimer & Co. Inc. | |
|
Werbung
|
|||
| 11.03.15 | Ocular Therapeutix Outperform | RBC Capital Markets | |
| 30.01.15 | Ocular Therapeutix Outperform | Oppenheimer & Co. Inc. | |
Werbung
Werbung